A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy of Milnacipran in the Treatment of Irritable Bowel Syndrome.
Phase of Trial: Phase II
Latest Information Update: 15 Apr 2017
At a glance
- Drugs Milnacipran (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 01 Feb 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 05 Jan 2012 Additional lead trial investigator (Spencer D Dorn) identified as reported by ClinicalTrials.gov.
- 06 Dec 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.